Henry E. Pelish - 22 Dec 2025 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Scientific Officer
Signature
/s/ Nathan N. McConarty, attorney-in-fact
Issuer symbol
NUVL
Transactions as of
22 Dec 2025
Net transactions value
+$5,492
Form type
4
Filing time
23 Dec 2025, 16:31:19 UTC
Previous filing
17 Oct 2025
Next filing
07 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pelish Henry E. Chief Scientific Officer C/O NUVALENT, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE /s/ Nathan N. McConarty, attorney-in-fact 23 Dec 2025 0002029477

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $5,492 +5,085 +7.7% $1.08 71,048 22 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -5,085 -100% $0.000000 0 22 Dec 2025 Class A Common Stock 5,085 $1.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option are fully vested.